10 employees
ConoGenetix biosciences is a biotechnology company that focuses on the development of peptide-based drugs.
2002
$2M
from 1 investors over 1 rounds
conoGenetix biosciences GmbH raised $2M on April 23, 2012
Investors: Mey Capital Matrix GmbH